Hanlin Gao - Feb 23, 2023 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Chief Scientific Officer
Signature: /s/ Paul Kim as Attorney-in-Fact
Stock symbol: FLGT
Transactions as of: Feb 23, 2023
Transactions value $: -$25,130
Form type: 4
Date filed: 2/27/2023, 04:16 PM
Previous filing: Feb 17, 2023
Next filing: Mar 3, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Award	$0	+2.14K	+0.24%	$0.00	908K	Feb 23, 2023	Direct	F1
transaction	FLGT	Common Stock	Award	$0	+12.2K	+1.34%	$0.00	920K	Feb 23, 2023	Direct	F2
transaction	FLGT	Common Stock	Tax liability	-$25.1K	-794	-0.09%	$31.65	920K	Feb 23, 2023	Direct	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.
F2	Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
F3	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.